Risk factors and independent predictors of survival in patients with pulmonary epithelioid haemangioendothelioma. Review of the literature and a case report

Respirology ◽  
2006 ◽  
Vol 11 (6) ◽  
pp. 818-825 ◽  
Author(s):  
Randa M.S. AMIN ◽  
Kenzo HIROSHIMA ◽  
Takeshi KOKUBO ◽  
Masafumi NISHIKAWA ◽  
Makoto NARITA ◽  
...  
1997 ◽  
Vol 50 (12) ◽  
pp. 1029-1031 ◽  
Author(s):  
R K Pokharna ◽  
P K Garg ◽  
S D Gupta ◽  
U Dutta ◽  
R K Tandon

2018 ◽  
Vol 5 (3) ◽  
Author(s):  
David P Serota ◽  
Mary Elizabeth Sexton ◽  
Colleen S Kraft ◽  
Federico Palacio

Abstract Acinetobacter baumannii is a rare but emerging cause of fulminant community-acquired pneumonia (CAP-AB). We describe a patient from a rural area who developed acute respiratory distress syndrome and septic shock. We describe risk factors and characteristics of this syndrome and review published cases of CAP-AB from North America.


Lupus ◽  
2021 ◽  
Vol 30 (6) ◽  
pp. 1005-1009
Author(s):  
Luca Moroni ◽  
Paolo Righini ◽  
Giuseppe A Ramirez ◽  
Nicola Farina ◽  
Gaia Mancuso ◽  
...  

Catastrophic antiphospholipid syndrome (CAPS) is a life-threatening condition characterized by multiple thromboembolic events occurring in a short period of time, frequently accompanied by significant systemic inflammation. Aortic involvement is rare in antiphospholipid syndrome and it had been never described in the context of its catastrophic variant. Here, we report an unusual case of aortic occlusion as a debut manifestation of CAPS and discuss its clinical features with an up-to-date review of the literature to identify risk factors and clues for clinical practice.


2005 ◽  
Vol 5 (10) ◽  
pp. 2565-2569 ◽  
Author(s):  
Phuong-Thu T. Pham ◽  
Phuong-Chi T. Pham ◽  
Gabriel M. Danovitch ◽  
H. Albin Gritsch ◽  
Jennifer Singer ◽  
...  

2012 ◽  
Vol 127 (1) ◽  
pp. 23-25 ◽  
Author(s):  
Massimo Martino ◽  
Giuseppe Console ◽  
Letteria Russo ◽  
Giuseppe Messina ◽  
Barbara Lelluccia Giovanna D’Arro’ ◽  
...  

2021 ◽  
Vol 2021 (2) ◽  
Author(s):  
John P Murray ◽  
Angela Kerins

ABSTRACT Amantadine withdrawal syndrome (AWS) is a rare but recognized cause of severe and persistent altered mental status sometimes with co-occurring extrapyramidal symptoms. First described in a case series from 1987, its clinical manifestations have been characterized along a spectrum ranging from profound hypoactive delirium to hyperactive delirium with hallucinations. Risk factors for withdrawal include abrupt medication discontinuation, prolonged use, older age and underlying dementia. Herein we describe a case of a 52-year-old woman who presented with confusion, hallucinations, and coronavirus disease-2019 infection. She subsequently developed a prolonged hypoactive delirium after her amantadine was tapered and held. Her hypoactive delirium entirely resolved with resumption of amantadine confirming the diagnosis of AWS. This case illustrates the importance of slowly tapering dopaminergic medications and being aware of rare pharmacologic side effects.


Sign in / Sign up

Export Citation Format

Share Document